This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

584 * Wed, 8/4/2010, 2:00 PM - 3:50 PM CC-120 (West)
Analysis of Composite Endpoints, Surrogate Endpoints, and Multicenter Trials — Contributed Papers
Biopharmaceutical Section , ENAR
Chair(s): Lihan Yan, FDA
2:05 PM Statistical and Clinical Characteristics of Composite Endpoint in Clinical Studies Jeng Mah, Regulatory and Clinical Research Institute, Inc.
2:20 PM Comparing the Performance of Composite Endpoints and Responder Definitions with a Unified Modeling Framework for Multiple Endpoints Within Clinical Trials David Andrae, PPD, Inc.
2:35 PM Total Migraine Freedom: A Potential Primary Endpoint to Assess Acute Treatment in Migraine Anthony J. Rodgers, Merck & Co., Inc.
2:50 PM A Nonparametric Test for the Validation of Surrogate Endpoints Xiaopeng Miao, Boston University School of Public Health ; Yong-Cheng Wang, Biogen Idec ; Ashis Gangopadhyay, Boston University
3:05 PM Statistical Challenges and Issues Related to Multiregion Trials Sibabrata Banerjee, Merck & Co., Inc. ; Lucy Shneyer, Merck & Co., Inc.
3:20 PM Expected Frequency of Allowed Forced Allocations in a Multicenter Clinical Trial Suvajit Samanta, Merck Research Laboratories ; Olga Kuznetsova, Merck Research Laboratories
3:35 PM Effect of Patient Allocation Schemes on the Power of a Test for Treatment Effect Fanni Natanegara, Eli Lilly and Company ; Christel Faes, Hasselt University ; Geert Molenberghs, I-BioStat ; Craig Mallinckrodt, Eli Lilly and Company

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.